Blood-brain barrier damage accelerates the accumulation of micro- and nanoplastics in the human central nervous system

被引:3
|
作者
Xie, Jian [1 ,2 ]
Ji, Jiale [1 ,2 ]
Sun, Yun [1 ,2 ]
Ma, Yifan [1 ,2 ]
Wu, Di [1 ,2 ]
Zhang, Zhijun [1 ,2 ,3 ]
机构
[1] Southeast Univ, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing 210009, Jiangsu, Peoples R China
[2] Southeast Univ, Inst Neuropsychiat, Sch Med, Lab Dev Genes & Human Dis,Jiangsu Prov Med Key Dis, Nanjing 210009, Jiangsu, Peoples R China
[3] Chinese Acad Sci, Shenzhen Univ Adv Technol, Brain Cognit & Brain Dis Inst, Shenzhen Inst Adv Technol,Fac Life & Hlth Sci,Dept, Shenzhen 518055, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Microplastics; Nanoplastics; Human cerebrospinal fluid; Neuro; -inflammation; MICROPLASTICS; IMPAIRMENT; EXPOSURE; DISEASE;
D O I
10.1016/j.jhazmat.2024.136028
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The widespread use of plastics has led to increased micro- and nanoplastics (MNPs) pollution, resulting in significant environmental challenges and concerns about potential harm to human health. This study investigated whether certain types of MNPs can accumulate in the human central nervous system (CNS) and trigger inflammatory responses, particularly after CNS infection. Our analysis of 28 cerebrospinal fluid (CSF) samples from 28 patients with or without CNS infection revealed that only polystyrene (PS), polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC) were capable of selectively entering the human CNS. Concentrations of PP and PE were positively correlated with the CSF albumin index. The levels of interleukin-6 (IL-6) and interleukin-8 (IL-8) were significantly increased in patients with CNS infections. However, concentrations of MNPs were not significantly associated with CSF levels of IL-6 or IL-8. Overall, these findings suggest that specific MNPs can
引用
收藏
页数:10
相关论文
共 50 条
  • [31] ABSENCE OF BLOOD-BRAIN BARRIER FROM CERTAIN AREAS OF CENTRAL NERVOUS SYSTEM
    WILSON, CW
    BRODIE, BB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1961, 133 (03): : 332 - &
  • [32] Exposure of quantum dots in the nervous system: Central nervous system risks and the blood-brain barrier interface
    Guan, Shujing
    Tang, Meng
    JOURNAL OF APPLIED TOXICOLOGY, 2024, 44 (07) : 936 - 952
  • [33] Blood-brain barrier damage in children with central nervous system infections (vol 94, pg 458, 1995)
    Hung, KL
    Tsai, ML
    Chen, WC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1996, 95 (03) : U4 - U4
  • [34] Central nervous system complications of diabetes mellitus - A perspective from the blood-brain barrier
    Mooradian, AD
    BRAIN RESEARCH REVIEWS, 1997, 23 (03) : 210 - 218
  • [35] Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease
    Liu, Xi
    Shen, Ling
    Han, Bing
    Yao, Honghong
    NON-CODING RNA RESEARCH, 2021, 6 (03): : 130 - 138
  • [36] Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
    Alavijeh M.S.
    Chishty M.
    Qaiser M.Z.
    Palmer A.M.
    NeuroRX, 2005, 2 (4): : 554 - 571
  • [37] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Galor, Anat
    Ference, Sandra J.
    Singh, Arun D.
    Lee, Michael S.
    Stevens, Glen H. J.
    Perez, Victor L.
    Peereboom, David M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (01) : 45 - 49
  • [38] Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier
    Summerfield, Scott G.
    Zhang, Yanyan
    Liu, Houfu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (02): : 294 - 305
  • [39] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Goldstein, Debra A.
    Tessler, Howard H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (06) : 976 - 976
  • [40] Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier
    Mikitsh, John L.
    Chacko, Ann-Marie
    PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 11 - 24